Oracle Investment Management »

Accelerate Diagnostics Inc - US shares owned by Oracle Investment Management

Quarter-by-quarter ownership of Accelerate Diagnostics Inc - US (AXDX) shares owned by Oracle Investment Management from 13F filings

Historical chart of Oracle Investment Management investment in Accelerate Diagnostics Inc - US

Tip: Access up to 7 years of quarterly data

All positions including Accelerate Diagnostics Inc - US held by Oracle Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Accelerate Diagnostics Inc - US by Oracle Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $437k 112k 3.92
2023-09-30 $785k 137k 5.75

More positions owned by Oracle Investment Management

Biohaven (BHVN)
Pacific Biosciences Calif In Call Call Option
Teladoc Health Call Call Option
Pacific Biosciences of California (PACB)
Quidel Corp (QDEL)
Quidelortho Corp Call Call Option
Eyepoint Pharmaceuticals Com New (EYPT)
Springworks Therapeutics Call Call Option
Ardelyx Call Call Option
Springworks Therapeutics (SWTX)
Ardelyx (ARDX)
Eyepoint Pharmaceuticals Call Call Option
Forian Ord (FORA)
Biohaven Call Call Option
BioCryst Pharmaceuticals (BCRX)

View all positions for Oracle Investment Management

Top funds holding Accelerate Diagnostics Inc - US

Griffin Asset Management
Vanguard Group
Peter B. Cannell & Co
Oracle Investment Management
TCI Wealth Advisors
Belpointe Asset Management
Warberg Asset Management
Ironwood Wealth Management
Susquehanna International
Citadel Advisors
Tudor Investment Corporation
Millennium Management
Tejara Capital
Hanson McClain Advisors
Thompson Investment Management

View all funds holding Accelerate Diagnostics Inc - US